Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
3- 100000 SHARE BUYS 6/1 BUYS VS SELLS $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Is everyone aware Nova mentis (NOVA -Can) is a member of the Psychedelic Stock Index (ETF)?? It just launched in January. Talk about exposure!
Good things coming to this company!!
NMLSF @ .10: Great to see partner MMEDF headed to Nasdaq
$NMLSF Nova Mentis Autism Clinical Study Approved by Institutional Review Board
Press Release | 02/25/2021
Nova Mentis Autism Clinical Study Approved by Institutional Review Board
Canada NewsWire
VANCOUVER, BC, Feb. 25, 2021
VANCOUVER, BC, Feb. 25, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a leader in the development of psilocybin and other psychedelic compounds with broad cognitive, behavioral, and peripheral physiologic effects, has received approval for its first clinical program in Autism Spectrum Disorder (ASD). The Company has obtained Institutional Review Board (IRB) approval of its protocol for a US-based Observational Study (NM-101): "Microbiotic Diversity in Autism Spectrum Disorder (ASD): Improving Diagnostics by Differentiating Subtypes."
"It's exciting to have ethical approval for our clinical efforts, as this externally validates the unmet clinical need and the importance of this research," stated Julia V. Perederiy, PhD, NOVA's Lead Scientist and Principal Investigator on this study.
The Institutional Review Boards (IRBs) are ethics committees designed to help the FDA and other regulatory agencies ensure that companies employ rigorous protocol standards and adhere to strict regulations surrounding the ethical treatment of human subjects. NOVA's IRB approval represents significant progress along the drug approval pathway, gathering data to support conversations with regulatory agencies and to help design upcoming ASD clinical trials for NOVA's lead drug candidates.
The objective of NM-101 is to identify subtle biological patterns in ASD that may underlie known behavioral phenotypes. Positive results will help improve: (1) accuracy of diagnosis, (2) design of next-generation therapeutic molecules, and (3) monitoring of treatment response. Leveraging proprietary machine learning algorithms, NOVA will incorporate diverse biomarker datasets into a Diagnostic Index, which will include gut microflora, epigenetics, and cognitive/behavioral evaluations.
About Nova Mentis Life Science Corp.
Nova Mentis Life Science Corp. is a Canadian-based biotechnology company that is focused on the emerging field of serotonergic psychedelic medicine, such as psilocybin and its related tryptamine derivatives. The Company is a global leader in this field by integrating the latest state-of-the-art medical and scientific technology into its drug development program. The goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder (ASD).
For further information on the Company, please visit https://www.novamentis.ca or email info@novamentis.ca.
On Behalf of the Board
Will Rascan, President & CEO
Nova Mentis Life Science Corp.
Twitter: @novamentislsc
Instagram: @novamentislsc
Facebook: @novamentislsc
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause Nova Mentis Life Science's actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.
SOURCE Nova Mentis Life Science Corp.
Effective Feb. 25,2021 LIBFD will change to NMLSF:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
NOW what is Nova/Liberty trading under??
LIBFF or LIBFD I'm not getting anything today under either
Liberty Leaf Hldgs Ltd. changed to Nova Mentis Life Sciences Corp. and a one for 4 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
Liberty Leaf's Subsidiary Just Kush Enters Into Genetics Purchase & Services Agreement With Rubicon Organics
Canada NewsWire
VANCOUVER, Dec. 19, 2019
VANCOUVER, Dec. 19, 2019 /CNW/ - Liberty Leaf Holdings Inc. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) ("Liberty Leaf" or the "Company") announced today that its subsidiary, Just Kush Enterprises Ltd. ("Just Kush"), has entered into a genetics purchase and services agreement with Vintages Organic Cannabis Company Inc., a wholly owned subsidiary of Rubicon Organics, Inc. ("Rubicon"), whereas Just Kush shall provide to Rubicon new rare genetics to expand its genetic library, in exchange, Rubicon shall support Just Kush with services including assistance with cannabis sales and certain crop consulting.
"We are pleased to have these genetics available which in turn allows us the opportunity to work alongside such a well-respected team at Rubicon," commented Dr. Robert Jackman, Just Kush's Quality Assurance Manager. "With our extensive genetics library, we are focussed on and have retained the Kush dominant cultivars that best complement our state-of-the-art, proprietary aeroponic grow system."
Jackman further adds: "This 'Made in BC' agreement with Rubicon will allow us to tap into the provincial retail markets sooner than later with our own branded products, once Rubicon has successfully secured its sales amendment from Health Canada."
About Rubicon Organics Inc.
Rubicon Organics holds a licence to cultivate and process cannabis and is focused on cultivating and branding certified organic, super-premium cannabis at its flagship 125,000-square-foot state-of-the-art hybrid greenhouse located on a 20-acre property in Delta, B.C., Canada.
About Just Kush Enterprises Ltd.
Just Kush has received its Standard Cultivation, Standard Processing and Sale for Medical Purposes License from Health Canada, and has a production facility situated on 13 acres in the Okanagan Valley near Oliver, B.C. Plans include the cultivation of premium, small batch, terpene-rich Kush dominant cultivars selected for their different levels of THC & CBD.
About Liberty Leaf Holdings Ltd.
Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing and value-added cannabis products within this dynamic and fast-growing sector.
On Behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Phone: 778-819-0244
Toll Free: 1-833-LIB-LEAF (542-5323)
Twitter: @LibertyLeafCSE
Facebook: LibertyLeafCSE
Instagram: libertyleafcse
Neither the Canadian Securities Exc
Joint venture NEWS with AgraFlora.
Get it joint (rolled) venture.
https://mailchi.mp/1e71e44cf2d2/agraflora-organics-announces-completion-of-name-change-and-forward-split-662451
News: $LIBFF Milestone Moment: Liberty Leaf's Subsidiary Just Kush Receives Confirmation of Readiness Notice from the Cannabis Licensing Division of Health Canada
Milestone Moment: Liberty Leaf's Subsidiary Just Kush Receives Confirmation of Readiness Notice from the Cannabis Licensing Division of Health Canada Canada NewsWire VANCOUVER, April 1, 2019 VANCOUVER , April 1, 2019 /CNW/ - Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: ...
In case you are interested https://marketwirenews.com/news-releases/milestone-moment-liberty-leaf-s-subsidiary-just-kush-receives-confirmation-of-readiness-notice-from-the-cannabis-licensing-division-of-health-canada-7923314.html
@LibertyLeafCSE $LIBFF $LIB HUGE and off to the races>>
Liberty Leaf’s Subsidiary Just Kush Receives Confirmation of Readiness Notice from the Cannabis Licensing Division of Health Canada https://www.libleaf.ca/news-releases/2019/04/01/liberty-leaf-announces-resignation-of-director-2-2/
$MJ $CRON $ACB $NBEV $CURLF $CGC $VSPC $PYX $TLRY $OGRMF $APHA
From what I've read it can take Health Canada up to 300 days to approve or deny a application. I hope that isn't the case for Liberty Leaf since they have been ready to grow since November. Some applicants haven't even started construction. Hoping ready to grow facilities get moved to the top of the list. GLTA
January 9,2018 LIBFF closed @ .7913. With this low float, we will see it again!!
Lookin GOOD. This is gonna explode when they get approved. It;s coming
Liberty Leaf trades lightly on the OTC, but trades heavy on the CSX. Today's CSX volume 2,195,881 OTC volume 109,200. Way above average for both, and way up. License news maybe? Americans are still buying Tilray and Canopy when these small caps will probably beat them to profitability. Why buy over bloated behemoths when you can invest in lean mean small caps hungry for growth. Literally:) GLTA
Fingers crossed!
LIBFF.... Something in the works!!
It's frustrating that Health Canada is making all these growers, with state of the art facilities, wait so long for their licenses. Especially with a supply shortage.
It's obvious from the Liberty Leaf website photos that the facility is complete, and ready to grow. Health Canada is forcing small cap growers to sit and wait while they shuffle papers.
Over 1000 businesses are waiting for cannabis licenses right now. Hopefully since LL was ready early in the second wave they are near the top of the stack.
Getting a license is the golden ticket. Investors will be moving to licensed companies for the safety of licensed revenue streams. As a shareholder I'm hoping Liberty Leaf gets that golden ticket soon. GLTA
I would not waste my money and time on this stock.
Liberty Leaf is a cannabis business accelerator, Liberty Leaf makes carefully considered investments in growth-oriented, legal cannabis ventures. Here are our leading investments to date:
North Road Ventures:
North Road Ventures was acquired by Liberty Leaf in October, 2016. It is an emerging distributor of cultivated and manufactured cannabis products to licenced legal retailers. The company is expanding into the recreational market. North Road currently occupies a leased commercial space in Metro Vancouver. North Road has an application pending with Health Canada for a ACMPR license.
Just Kush
Liberty Leaf has Acquired the majority interest in Just Kush – a late-stage ACMPR Applicant and a company in control of a current MMAR-licensed facility. The acquisition puts two ACMPR licences in play, strengthening Liberty Leaf’s strategic position as a forward-thinking, vertically-integrated cannabis company.
Signature Cannabis:
Signature Cannabis Retail Ltd. (“Signature Cannabis”) is the retail channel and a wholly-owned subsidiary of Liberty Leaf, with an operational network slated to include flagship stores, as well as corporate-owned satellite stores, partner operations and online dealer-support networks.
Starting in B.C., the plan is to serve as many communities across Canada as possible. The corporate-owned flagship stores would each range in size from approximately 1,500-2,500 square feet, while partner locations would each be approximately 500-1,000 square feet.
Esev Genetics:
ESEV Genetics is developing the world’s first genomic platform for high value crop and advancing medicine and foods plant-derived solutions, to improve people’s life.
Liberty Leaf Announces Affirmation of Readiness Submission to Health Canada by Just Kush https://finance.yahoo.com/news/liberty-leaf-announces-affirmation-readiness-161100714.html?soc_src=hl-viewer&soc_trk=tw via @YahooFinance
We need that posted.
Earnings Date??? and numbers?? - anyone have it??
I do have a lot of confidence in this one.
Just Kush State-of-the-Art Facility Buildout Nears Completion https://www.newswire.ca/news-releases/just-kush-state-of-the-art-facility-buildout-nears-completion-687392491.html
Senate Approves Cannabis Bill C-45 3rd Reading
Vote result on third reading of Bill #C45, as amended: Yeas: 56 Nays: 30 Abstentions: 1 https://t.co/wp8fYQUZ1V #SenCA #cdnpoli #Cannabis pic.twitter.com/NZ9Xya2bGV
— Senate of Canada (@SenateCA) June 8, 2018
Canadian Senate Approves Cannabis Legalization Bill https://plus.google.com/u/0/+WeedWarrior/posts/XqxYeYwLGXx
Looks like sector turning around. Ready to see Liberty start moving back up. Need license, and/or some news. $LIBFF
I hear you. These guys need to release some news while we wait on a license, and the bull market to return.
WTF with this stock!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
When the sector starts moving, Liberty should move up too. IMHO. Could be any time now. $LIBFF
When is this piece of shit going to get any licenses?
Easy triple from here imo. Bring the licenses and the news! $LIBFF
Let's go Liberty. Give us something. $LIBFF
Yes Sir!! One day at a time! Must be getting almost there. Over 11.81% today so far!!
Keep it up Liberty. Marching towards legalization one day at a time. $LIBFF
Looking a lot better...let's see some newwwws. $LIBFF
Roundhouse Radio Vancouver 3/3/18
http://cirh2.streamon.fm/listen-pl-14869?smc=22#.WpstzvjPKkA.twitter
Liberty Leaf CEO talks starting ~ Minute 31-32
LIBFF and Blox Labs, Inc. Near Completion of cannaBLOX White Paper
- Companies in partnership to create cannaBLOX, a blockchain-based software smart contract platform for the legalized cannabis industry
- cannaBLOX blockchain software is a supply chain management platform designed to ease logistical bottlenecks, minimize fraud, assist in taxation and ensure regulatory compliance
- LIBFF and BLLXF have completed preliminary input and analysis in their joint phase one development of cannaBLOX
Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) have announced progress on their joint development of phase one of cannaBLOX, the blockchain-based smart contract platform for the legalized cannabis industry (http://nnw.fm/lw2qG).
Blox Labs is working to complete its white paper on cannaBLOX, and a satellite development team has been created in Eastern Europe that specializes in blockchain and decentralized application technologies. The initial framework and analysis segment of the white paper is now complete.
The white paper includes cannabis industry analysis, schematic design, project scoping and itemizing utility and process flow details. The new development team is specialized in omni-language development in Ethereum.
LIBFF is a Canada-based company which has a focus on building a portfolio of cannabis-related businesses. In this sector, it is targeting cultivation, processing and the development of CBD/THC pet and supply-chain products. Its portfolio includes a 100 percent interest in North Road Ventures and a 60 percent interest in Just Kush, strengthening LIBFF’s position as a vertically-integrated cannabis company. North Road is an emerging distributor of cultivated and manufactured cannabis products to licensed retailers. Just Kush is a late-stage applicant for Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Blox Labs developments include software for blockchain, smart contracts and decentralized application technologies. It is entering the Canadian cannabis market with cannaBLOX software, a blockchain solution targeted at cannabis seed-to-sale verification.
For more information, visit the company’s website at www.LibLeaf.ca
LIBFF Subsidiary Inks Deal with Cannabis Compliance Inc.
Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) president and CEO Will Rascan this morning announced that the company’s wholly-owned subsidiary, North Road Ventures, has signed an agreement with Cannabis Compliance Inc. (“CCI”). Per the terms of the agreement, CCI will be responsible for assuring the Good Manufacturing Practice (“GMP”)-compliant processing and production of North Road’s products containing cannabis. GMP requirements ensure that the products manufactured are safe and of consistently high quality for their intended use. “This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the manufacture and sale of a wide range of medicinal-quality products for both human and veterinary use – not just cannabis and cannabis-containing finished products,” Robert Jackman, scientific project manager/fulfillment, stated in the news release.
To view the full press release, visit http://nnw.fm/QOyt3
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector. Liberty Leaf owns a 60% interest in Just Kush, along with 100% wholly-owned North Road Ventures, are both late-stage applicants under Health Canada’s ACMPR. For more information, visit the company’s website at www.LibLeaf.ca.
Liberty Leaf Holdings' Subsidiary North Road Ventures Signs Agreement with Cannabis Compliance Inc. to Facilitate In-House GMP-Compliant Manufacturing
Canada NewsWire
VANCOUVER, March 1, 2018
Company on track to produce finished cannabis products such as edibles, cosmetics, topicals, human and veterinary natural health products.
VANCOUVER, March 1, 2018 /CNW/ - Will Rascan, President and CEO of Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) ("Liberty Leaf" or "the Company"), announced today the signing of an agreement between North Road Ventures, a wholly-owned subsidiary of the Company, and Cannabis Compliance Inc. ("CCI"). Under the terms of the agreement, CCI will be responsible for shepherding the Good Manufacturing Practice (GMP)-compliant processing/production of North Road's cannabis-containing and other finished products.
Liberty Leaf is a Canadian-based public company whose objective is to be at the forefront of the cannabis industry, accelerating vertically integrated, revenue-generating businesses within this rapidly growing sector.
Canada is the only G7 country to legalize (expected to occur this summer) both medical and recreational cannabis on a national level. To facilitate this, Canada has established the most stringent requirements for commercial production found anywhere. Achieving compliance means following strict protocols regarding security system designs and procedures, quality assurance programs, record keeping, sanitation and standard operating procedures. At the heart of these requirements are GMPs that ensure the manufacture of finished products that are safe and of a consistently high quality for their intended use.
With more than a decade of extensive experience in cannabis compliance matters, CCI is the ideal partner for guiding North Road to successful authorized/licensed GMP manufacture of finished products, especially cannabis and cannabis-containing products.
A GMP Manufacturing Facility Expected to Deliver on Tremendous Promise
"We are extremely excited to be working with CCI in establishing GMP manufacturing capabilities in-house," said Robert Jackman, Scientific Project Manager/Fulfillment for the Company. "This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the manufacture and sale of a wide range of medicinal-quality products for both human and veterinary use – not just cannabis and cannabis-containing finished products."
A Unique Distribution Strategy and Expansion into Natural Health Products
North Road Ventures has a distribution strategy that has not been implemented by any other organization in the cannabis industry.
"North Road plans to make available to both pharmacies and licensed retailers our exclusive medicinal-quality cannabis, cannabis-related products and racking jobber service," Rascan said. "The ability for us to expand on our model by including Natural Health Products (NHPs) for human and veterinary use as well as cosmetics/beauty products, topicals, concentrates, foods/edibles and other high-quality products for distribution holds tremendous growth potential for our company."
According to Rascan, these new developments represent an extension of North Road's existing business model. CCI's efforts in helping the Company acquire new licenses will be complementary to the Company's current ACMPR license application.
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a Canadian-based public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply chain products within this dynamic and fast-growing sector.
Liberty Leaf's late-stage ACMPR portfolio consists of a 60% interest in Just Kush and 100% of North Road Ventures.
On behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Phone: 778-819-0244
Twitter: @LibertyLeafCSE
Facebook: LibertyLeafCSE
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The Company disclaims any intention or obligation to revise or update such statements.
SOURCE Liberty Leaf Holdings
Read more at http://www.stockhouse.com/companies/bullboard#RPs347ORTxyDSheA.99
Followers
|
17
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1456
|
Created
|
10/11/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |